To: Investor2 who wrote (8808 ) 3/29/2020 10:22:20 AM From: Kirk © Respond to Here is some more great news about why it is nice to live in the Bay Area... access to these potential treatments. Who gets access to experimental drug? lkrieger@bayareanewsgroup.com With little but supportive care to help sick people, global hopes are pinned on Gilead’s experimental antiviral agent called remdesivir . Demand was further fueled by President Donald Trump, who in news conferences has promoted remdesivir and other unproven drugs. In January, in the first known U.S. case of COVID- 19, the disease caused by the coronavirus, a man in Snohomish County, Washington, improved after receiving a single treatment.Palo Alto resident Monica Yeung Arima, hospitalized this month with pneumonia after contracting the coronavirus on a cruise in Egypt, began to improve after intravenous treatment. “But after the second application, I am already turning around. My fever stabilized. My oxygen levels stabilized.” Full story mercurynews-ca.newsmemory.com ?publink=491fcfa5b_13435ad“It’s not a toxic drug. It’s generally welltolerated, which is amazing. When you think of a drug like that — if it’s not going to cause a patient that much harm and you have a little evidence of benefit and the patient might die without treatment, of course, you want to use it as much as you can.”
